These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 5523265)
1. [Drug-induced icterus caused by chloroquine]. Klemm G Z Gesamte Inn Med; 1970 Apr; 25(8):374-6. PubMed ID: 5523265 [No Abstract] [Full Text] [Related]
2. [Intrahepatic cholestasis following ovosiston]. Kraatz G; Linke A Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1194-6. PubMed ID: 4135044 [No Abstract] [Full Text] [Related]
3. [Therapy of acute viral hepatitis]. Lindner H Landarzt; 1967 Jul; 43(19):910-8. PubMed ID: 4182982 [No Abstract] [Full Text] [Related]
4. [Cholestasis from ticlopidine: two clinical cases]. Varvello L; Arnò C; Coggiola M; Ramassotto E; Pascale C Ann Ital Med Int; 2002; 17(4):252-5. PubMed ID: 12532564 [TBL] [Abstract][Full Text] [Related]
10. [Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes]. Alkabes M; Ancona A; Palmieri R; Palmieri G; Zambruno E Clin Ter; 1980 Dec; 95(6):637-54. PubMed ID: 7011665 [No Abstract] [Full Text] [Related]
11. Anti-cholestatic activity of HD-03, a herbal formulation in thioacetamide (TAA)-induced experimental cholestasis. Mitra SK; Venkataranganna MV; Gopumadhavan S; Sundaram R Indian J Exp Biol; 1999 Apr; 37(4):409-10. PubMed ID: 10641180 [TBL] [Abstract][Full Text] [Related]
12. [Epomediol-induced modifications of the biohumoral picture in hepatic cirrhosis with or without cholestasis]. Alberti A; Andreuzzi B; Santese R; Rotondo F Clin Ter; 1983 Feb; 104(3):227-33. PubMed ID: 6345051 [No Abstract] [Full Text] [Related]
13. [Anicteric form of progressive familial intrahepatic cholestasis (Byler syndrome)]. Masmoudi A; Hadj-Taieb I; Kammon T; Mseddi M; Boudaya S; Chaabouni M; Hachicha M; Turki H Ann Dermatol Venereol; 2008 Mar; 135(3):228-30. PubMed ID: 18374858 [No Abstract] [Full Text] [Related]
14. [A new therapeutic agent for the migrainous "terrain"]. Cabanié M; Schwartz R Sem Ther; 1964 Feb; 40(2):108-10. PubMed ID: 5878928 [No Abstract] [Full Text] [Related]
15. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients. George R; Stevens A; Berkenbosch JW; Turpin J; Tobias J South Med J; 2002 Nov; 95(11):1276-9. PubMed ID: 12539993 [TBL] [Abstract][Full Text] [Related]
16. Severe cholestasis and renal failure associated with the use of the designer steroid Superdrol (methasteron): a case report and literature review. Nasr J; Ahmad J Dig Dis Sci; 2009 May; 54(5):1144-6. PubMed ID: 18720005 [No Abstract] [Full Text] [Related]
17. [Clinical evaluation of a new choleretic administered in normal and high doses to patients with chronic hepatocholecytopathies]. Petracca EG; Cavazzuti C Clin Ter; 1983 Oct; 107(2):109-19. PubMed ID: 6362962 [No Abstract] [Full Text] [Related]
18. [Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid]. Mörk H; al-Taie O; Klinge O; Scheurlen M Z Gastroenterol; 1997 Dec; 35(12):1087-91. PubMed ID: 9487641 [TBL] [Abstract][Full Text] [Related]
19. [Prevention of clogging of biliary stents by administration of levofloxacin and ursodeoxycholic acid]. Sciumè C; Geraci G; Pisello F; Facella T; Li Volsi F; Modica G Chir Ital; 2004; 56(6):831-7. PubMed ID: 15771038 [TBL] [Abstract][Full Text] [Related]